Marco Valgimigli


Ontology type: schema:Person     


Person Info

NAME

Marco

SURNAME

Valgimigli

Publications in SciGraph latest 50 shown

  • 2022-07-18 Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry in CLINICAL RESEARCH IN CARDIOLOGY
  • 2022-06-13 P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention in NATURE REVIEWS CARDIOLOGY
  • 2022-04-28 Pharmacosimulation of delays and interruptions during administration of tirofiban: a systematic comparison between EU and US dosage regimens in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2022-02-17 Left atrial adaptation in ischemic heart disease: insights from a cardiovascular magnetic resonance study in THE INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
  • 2021-10-22 Atrial Interventions in PRACTICAL 3D ECHOCARDIOGRAPHY
  • 2021-10-22 Normal 3DE Anatomy of Atrial Septum: Image Display and Anatomical Specimen Correlations in PRACTICAL 3D ECHOCARDIOGRAPHY
  • 2021-10-22 3DE Anatomy of Normal Aortic Valve and Root. Image Display and Anatomic Correlations in PRACTICAL 3D ECHOCARDIOGRAPHY
  • 2021-08-23 Bleeding avoidance strategies in percutaneous coronary intervention in NATURE REVIEWS CARDIOLOGY
  • 2021-04-21 Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure in JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
  • 2021-03-11 Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2020-11-22 Impact of optical coherence tomography findings on clinical outcomes in ST-segment elevation myocardial infarction patients: a MATRIX (Minimizing Adverse Hemorrhagic Events by Trans-radial Access Site and angioX) OCT sub-study in THE INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
  • 2020-10-24 Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis in CLINICAL RESEARCH IN CARDIOLOGY
  • 2020-10-16 Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial in CARDIOVASCULAR DIABETOLOGY
  • 2020-08-04 Therapeutic Considerations with Revascularization in Chronic Kidney Disease: Radial Versus Femoral Arterial Access in KIDNEY DISEASE IN THE CARDIAC CATHETERIZATION LABORATORY
  • 2020-02-24 Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale in JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
  • 2020-01-31 The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial in CLINICAL RESEARCH IN CARDIOLOGY
  • 2020-01-10 Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial in CLINICAL RESEARCH IN CARDIOLOGY
  • 2019-12-11 Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial in CLINICAL RESEARCH IN CARDIOLOGY
  • 2019-06-13 Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies—meta-analysis of prospective studies in EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
  • 2018-07-04 Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention in NATURE REVIEWS CARDIOLOGY
  • 2017-08-29 Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies in DRUGS
  • 2017-05-19 Trans-radial and Trans-femoral Intervention in TRANSRADIAL APPROACH FOR PERCUTANEOUS INTERVENTIONS
  • 2017-01-17 Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease in CURRENT CARDIOLOGY REPORTS
  • 2016-12-02 Atrial Fibrillation on Non-vitamin K Antagonist Oral Anticoagulant Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina in ATRIAL FIBRILLATION AND PERCUTANEOUS CORONARY INTERVENTION
  • 2016-09-08 Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors in CLINICAL RESEARCH IN CARDIOLOGY
  • 2016-04-21 Reducing Microvascular Dysfunction in Revascularized Patients with ST-Elevation Myocardial Infarction by Off-Target Properties of Ticagrelor versus Prasugrel. Rationale and Design of the REDUCE-MVI Study in JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
  • 2016-04-01 External validity of the “all-comers” design: insights from the BIOSCIENCE trial in CLINICAL RESEARCH IN CARDIOLOGY
  • 2015-12-22 Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials in CLINICAL RESEARCH IN CARDIOLOGY
  • 2015-12-18 Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study in JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
  • 2015-05-19 Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization in JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
  • 2015-01-28 Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions in NETHERLANDS HEART JOURNAL
  • 2015 Radial and Femoral Access in Percutaneous Intervention in CONTROVERSIES IN CARDIOLOGY
  • 2014-05-18 Stable Angina Pectoris in CURRENT ATHEROSCLEROSIS REPORTS
  • 2014-01-07 Scientific Foundation and Possible Implications for Practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX (MATRIX) Trial in JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
  • 2012 Aortic Counterpulsation in ENCYCLOPEDIA OF INTENSIVE CARE MEDICINE
  • 2011-09 Triple Antiplatelet Therapy in Acute Coronary Syndromes in DRUGS
  • 2011-01-01 Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2010-03-11 Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials in CLINICAL RESEARCH IN CARDIOLOGY
  • 2010-02-16 Poor response to clopidogrel: current and future options for its management in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2009-02-04 Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2009-01 Defining the Role of Platelet Glycoprotein Receptor Inhibitors in STEMI in DRUGS
  • 2008-06-17 Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design in CARDIOVASCULAR DRUGS AND THERAPY
  • 2007-01-01 Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants: Effects on Survival in Myocardial Infarction Patients in MOLECULAR MEDICINE
  • 2006-03-31 Reproducibility of intravascular ultrasound radiofrequency data analysis: implications for the design of longitudinal studies in THE INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
  • 2006-03 Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure–volume loops in NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE
  • 2005-08 Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology in THE INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
  • 2005-03 Assessment of acute myocardial infarction evolution in patients undergoing primary angioplasty or thrombolytic therapy: A gated-SPECT longitudinal evaluation study in JOURNAL OF NUCLEAR CARDIOLOGY
  • 2004-05 High-Dose BoluS TiRofibAn and Sirolimus Eluting STEnt versus Abiciximab and Bare Metal Stent in Acute MYocardial Infarction (STRATEGY) Study—Protocol Design and Demography of the First 100 Patients in CARDIOVASCULAR DRUGS AND THERAPY
  • 2001-11 Neurohormones, Cytokines and Programmed Cell Death in Heart Failure: A New Paradigm for the Remodeling Heart in CARDIOVASCULAR DRUGS AND THERAPY
  • 2001-04-01 Serum xanthine oxidase in human liver disease in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.411656.1", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.11598.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.154185.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9024.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7177.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411149.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10403.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5734.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.29078.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411482.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416167.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412353.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5337.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239395.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.59734.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.18887.3e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.469433.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7400.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417406.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.483229.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5645.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.262863.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26790.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.436489.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417574.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6292.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415562.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26009.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5650.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.30760.32", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.12136.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8484.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411327.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6906.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267301.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9757.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412311.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418378.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412484.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414603.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.491605.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.508487.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416315.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7841.a", 
            "type": "Organization"
          }
        ], 
        "familyName": "Valgimigli", 
        "givenName": "Marco", 
        "id": "sg:person.01110472511.79", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-4353-7110"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110472511.79", 
          "https://orcid.org/0000-0002-4353-7110"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-12-01T07:13", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/person/person_834.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01110472511.79'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01110472511.79'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01110472511.79'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01110472511.79'


     

    This table displays all metadata directly associated to this object as RDF triples.

    107 TRIPLES      11 PREDICATES      56 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01110472511.79 schema:affiliation N03b0ce14f979417b864016bb9518177d
    2 grid-institutes:grid.10403.36
    3 grid-institutes:grid.11598.34
    4 grid-institutes:grid.12136.37
    5 grid-institutes:grid.154185.c
    6 grid-institutes:grid.18887.3e
    7 grid-institutes:grid.239395.7
    8 grid-institutes:grid.26009.3d
    9 grid-institutes:grid.262863.b
    10 grid-institutes:grid.267301.1
    11 grid-institutes:grid.26790.3a
    12 grid-institutes:grid.29078.34
    13 grid-institutes:grid.30760.32
    14 grid-institutes:grid.411149.8
    15 grid-institutes:grid.411327.2
    16 grid-institutes:grid.411482.a
    17 grid-institutes:grid.412311.4
    18 grid-institutes:grid.412353.2
    19 grid-institutes:grid.412484.f
    20 grid-institutes:grid.414603.4
    21 grid-institutes:grid.415562.1
    22 grid-institutes:grid.416167.3
    23 grid-institutes:grid.416315.4
    24 grid-institutes:grid.417406.0
    25 grid-institutes:grid.417574.4
    26 grid-institutes:grid.418378.1
    27 grid-institutes:grid.436489.4
    28 grid-institutes:grid.469433.f
    29 grid-institutes:grid.483229.6
    30 grid-institutes:grid.491605.f
    31 grid-institutes:grid.508487.6
    32 grid-institutes:grid.5337.2
    33 grid-institutes:grid.5645.2
    34 grid-institutes:grid.5650.6
    35 grid-institutes:grid.5734.5
    36 grid-institutes:grid.59734.3c
    37 grid-institutes:grid.6292.f
    38 grid-institutes:grid.6906.9
    39 grid-institutes:grid.7177.6
    40 grid-institutes:grid.7400.3
    41 grid-institutes:grid.7841.a
    42 grid-institutes:grid.8484.0
    43 grid-institutes:grid.9024.f
    44 grid-institutes:grid.9757.c
    45 schema:familyName Valgimigli
    46 schema:givenName Marco
    47 schema:identifier N8bd2120aad7d436095e43077de14f50b
    48 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110472511.79
    49 https://orcid.org/0000-0002-4353-7110
    50 schema:sdDatePublished 2022-12-01T07:13
    51 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    52 schema:sdPublisher Na890de9cacb14f43805e38eea4157b4b
    53 sgo:license sg:explorer/license/
    54 sgo:sdDataset persons
    55 rdf:type schema:Person
    56 N03b0ce14f979417b864016bb9518177d schema:affiliation grid-institutes:grid.411656.1
    57 sgo:isCurrent true
    58 rdf:type schema:OrganizationRole
    59 N8bd2120aad7d436095e43077de14f50b schema:name orcid_id
    60 schema:value 0000-0002-4353-7110
    61 rdf:type schema:PropertyValue
    62 Na890de9cacb14f43805e38eea4157b4b schema:name Springer Nature - SN SciGraph project
    63 rdf:type schema:Organization
    64 grid-institutes:grid.10403.36 schema:Organization
    65 grid-institutes:grid.11598.34 schema:Organization
    66 grid-institutes:grid.12136.37 schema:Organization
    67 grid-institutes:grid.154185.c schema:Organization
    68 grid-institutes:grid.18887.3e schema:Organization
    69 grid-institutes:grid.239395.7 schema:Organization
    70 grid-institutes:grid.26009.3d schema:Organization
    71 grid-institutes:grid.262863.b schema:Organization
    72 grid-institutes:grid.267301.1 schema:Organization
    73 grid-institutes:grid.26790.3a schema:Organization
    74 grid-institutes:grid.29078.34 schema:Organization
    75 grid-institutes:grid.30760.32 schema:Organization
    76 grid-institutes:grid.411149.8 schema:Organization
    77 grid-institutes:grid.411327.2 schema:Organization
    78 grid-institutes:grid.411482.a schema:Organization
    79 grid-institutes:grid.411656.1 schema:Organization
    80 grid-institutes:grid.412311.4 schema:Organization
    81 grid-institutes:grid.412353.2 schema:Organization
    82 grid-institutes:grid.412484.f schema:Organization
    83 grid-institutes:grid.414603.4 schema:Organization
    84 grid-institutes:grid.415562.1 schema:Organization
    85 grid-institutes:grid.416167.3 schema:Organization
    86 grid-institutes:grid.416315.4 schema:Organization
    87 grid-institutes:grid.417406.0 schema:Organization
    88 grid-institutes:grid.417574.4 schema:Organization
    89 grid-institutes:grid.418378.1 schema:Organization
    90 grid-institutes:grid.436489.4 schema:Organization
    91 grid-institutes:grid.469433.f schema:Organization
    92 grid-institutes:grid.483229.6 schema:Organization
    93 grid-institutes:grid.491605.f schema:Organization
    94 grid-institutes:grid.508487.6 schema:Organization
    95 grid-institutes:grid.5337.2 schema:Organization
    96 grid-institutes:grid.5645.2 schema:Organization
    97 grid-institutes:grid.5650.6 schema:Organization
    98 grid-institutes:grid.5734.5 schema:Organization
    99 grid-institutes:grid.59734.3c schema:Organization
    100 grid-institutes:grid.6292.f schema:Organization
    101 grid-institutes:grid.6906.9 schema:Organization
    102 grid-institutes:grid.7177.6 schema:Organization
    103 grid-institutes:grid.7400.3 schema:Organization
    104 grid-institutes:grid.7841.a schema:Organization
    105 grid-institutes:grid.8484.0 schema:Organization
    106 grid-institutes:grid.9024.f schema:Organization
    107 grid-institutes:grid.9757.c schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...